BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare
Chief Discovery Officer Yarlagadda S Babu sold $343K of BioCryst Pharmaceuticals, Inc.
Sold$343,200
$17.16Price
20,000Shares
−8%Stake
What BCRX did after the filing
- The stock from Wed, Mar 9 close, $18.45
- −47.5%
- S&P 500, same days
- +2.8%
Measured over 30 trading days, to the Apr 21 close.
Traded Mon, Mar 7. Filed Wed, Mar 9, 11:24 AM ET, during the session. Returns use the Mar 9 close and the Apr 21 close. Not investment advice.